Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AqueSys, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of primary open angle glaucoma
Participants are taking at least one and no more than four topical IOP-lowering medications.
You may not be if
Angle Closure Glaucoma
Participant has neovascular, uveitic or angle recession glaucoma or any glaucoma associated with vascular disorders
Clinically significant inflammation or infection in the study eye within 30 days prior to the preoperative visit (e.g., blepharitis, conjunctivitis, keratitis, uveitis, herpes simplex infection)
Presence of conjunctival scarring or prior conjunctival surgery or other conjunctival pathologies (e.g., pterygium) in the target quadrant
Clareo Health | Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants
